Thomas Mauget

发表

Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report

Mosoka P. Fallah, Pierre-Stéphane Gsell, Ana Maria Henao-Restrepo, 2017, The Lancet. Infectious diseases.

Eﬃ cacy and eﬀ ectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: ﬁ nal results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suﬃ t!)

M. Egger, M. Kieny, R. Grais, 2017 .

Effi cacy and eff ectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease : fi nal results from the Guinea ring vaccination , open-label , cluster-randomised trial ( Ebola Ça Suffi t ! )

M. Egger, M. Kieny, R. Grais, 2017 .

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

John-Arne Røttingen, Sema Mandal, Matthias Egger, 2017, The Lancet.

Effi cacy and eff ectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease : fi nal results from the Guinea ring vaccination , open-label , cluster-randomised trial ( Ebola Ça Suffi t ! )

R. Grais, J. Røttingen, S. Trelle, 2016 .